Effect of Magnesium Sulphate on Coagulation
Study Details
Study Description
Brief Summary
Arterial and venous thrombotic events are the clinical manifestation of postoperative hypercoagulability. Altered serum magnesium may play a role in the balance of coagulation. In this study, the investigators investigated the effect of magnesium sulphate on the postoperative coagulation change in total intravenous anesthesia (TIVA).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: group C control group |
Drug: normal saline
Group S received the same volume of isotonic saline as same method.
Other Names:
|
Experimental: group M magnesium group |
Drug: Magnesium Sulfate
Group M received 50 mg/kg of magnesium sulphate on 100 ml of isotonic saline over 10 minutes during the anesthesia induction, followed by the 15 mg/kg/h by continuous infusion during the operation
Other Names:
|
Outcome Measures
Primary Outcome Measures
- thromboelastography (TEG) analysis [twice]
10 minutes before the induction of anesthesia 10 minutes after the recovery from the anesthesia
Secondary Outcome Measures
- hemoglobin level [twice]
10 minutes before the induction of anesthesia 10 minutes after the recovery from the anesthesia
- platelet count [twice]
10 minutes before the induction of anesthesia 10 minutes after the recovery from the anesthesia
- international normalized ratio of prothrombin time (INR-PT) [twice]
10 minutes before the induction of anesthesia 10 minutes after the recovery from the anesthesia
- activated partial thromboplastin time (aPTT) [tiwce]
10 minutes before the induction of anesthesia 10 minutes after the recovery from the anesthesia
- serum magnesium level [twice]
10 minutes before the induction of anesthesia 10 minutes after the recovery from the anesthesia
Eligibility Criteria
Criteria
Inclusion Criteria:
- ASA Ⅰ-Ⅱ patients undergoing pelviscopic gynecologic operation under general anesthesia.
Exclusion Criteria:
-
Pregnancy
-
Previous known hematologic disorder
-
Recent medication interfering with hemostasis
-
Severe anemia
-
Liver disease
-
Cardiovascular or respiratory disease
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Seoul National University Bundang Hospital | Seongnam-si | Gyeonggi-do | Korea, Republic of | 463-707 |
Sponsors and Collaborators
- Seoul National University Bundang Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- TEG/Mg